Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Regulatory News (GSK)

Share Price Information for Glaxosmithkline (GSK)

Share Price is delayed by 15 minutes
Get Live Data
1,972.50    22.50 (1.15%)
Bid:
1,971.00
Ask:
1,971.50
Spread: 0.50 (0.025%)
Market Cap: £79.05b
GSK Live PriceLast checked at - London Stock Exchange

Intraday Glaxosmithkline Share Chart

GSK

11 Jul 2022 17:30

RNS Number : 0768S
FTSE Russell
11 July 2022
 

 

 

GSK (UK): Demerger of Haleon (UK)Changes in FTSE UK Index Series

11 July 2022

Further to the FTSE Russell notice released 15 June 2022 and subject to the completion of the demerger of Haleon (UK, non-constituent) from GSK (UK, constituent), please see details of affected indexes and effective dates below:

 

 

Index

Effective FromStart of Trading

FTSE 100 Index

18 July 2022

FTSE 350 Index

18 July 2022

FTSE All-Share Index

18 July 2022

FTSE 350 Higher Yield Index

18 July 2022

Techmark All Share Index

18 July 2022

FTSE UK Dividend + Index

18 July 2022

 

 

 

 

 

 

For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:

Australia

+1800 653 680

Hong Kong

+852 2164 3333

Japan

+81 3 6441 1440

London

+44 (0) 20 7866 1810

New York

+1866 551 0617

 

Alternatively please visit our website at www.ftserussell.com

Terms of Use | Copyright © 2022 FTSE Russell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FTSQFLFFLDLBBBF
Date   Source Headline
18th Nov 20253:30 pmRNSDirector/PDMR Shareholding
18th Nov 20257:00 amRNSTransaction in Own Shares
17th Nov 20257:00 amRNSTransaction in Own Shares
14th Nov 20257:00 amRNSTransaction in Own Shares
13th Nov 20253:30 pmRNSDirector/PDMR Shareholding
13th Nov 20257:00 amRNSTransaction in Own Shares
12th Nov 20253:30 pmRNSBlock listing Interim Review
12th Nov 20257:00 amRNSTransaction in Own Shares
11th Nov 20257:00 amRNSTransaction in Own Shares
10th Nov 20253:00 pmRNSGSK publishes provisional dividend dates
10th Nov 20257:00 amRNSTransaction in Own Shares
7th Nov 20257:00 amRNSTransaction in Own Shares
6th Nov 20257:00 amRNSTransaction in Own Shares
5th Nov 20257:00 amRNSTransaction in Own Shares
4th Nov 20257:00 amRNSTransaction in Own Shares
3rd Nov 20253:00 pmRNSTotal Voting Rights
3rd Nov 20257:00 amRNSTransaction in Own Shares
31st Oct 20257:00 amRNSTransaction in Own Shares
30th Oct 20253:30 pmRNSDirector/PDMR Shareholding
30th Oct 20257:00 amRNSTransaction in Own Shares
29th Oct 20257:05 amRNSTransaction in Own Shares
29th Oct 20257:00 amRNS3rd Quarter Results
28th Oct 20257:00 amRNSTransaction in Own Shares
28th Oct 20257:00 amRNSGSK ADC gets orphan drug designation in the EU
27th Oct 20257:00 amRNSTransaction in Own Shares
24th Oct 20257:00 amRNSBlenrep approved by US FDA in multiple myeloma
24th Oct 20257:00 amRNSTransaction in Own Shares
23rd Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 20257:05 amRNSPositive data for low carbon version Ventolin MDI
22nd Oct 20257:00 amRNSTransaction in Own Shares
22nd Oct 20257:00 amRNSLatozinemab data read out
21st Oct 20257:05 amRNSPositive CHMP Opinion for GSK on Shingrix PFS
21st Oct 20257:00 amRNSTransaction in Own Shares
21st Oct 20257:00 amRNSGSK share positive Ph3 data on tebipenem HBr
20th Oct 20257:00 amRNSTransaction in Own Shares
17th Oct 20257:00 amRNSTransaction in Own Shares
16th Oct 20253:30 pmRNSDirector/PDMR Shareholding
16th Oct 20257:00 amRNSTransaction in Own Shares
15th Oct 20253:30 pmRNSDirector/PDMR Shareholding
15th Oct 20257:00 amRNSTransaction in Own Shares
14th Oct 20257:00 amRNSGSK receives expanded Shingrix approval in China
14th Oct 20257:00 amRNSTransaction in Own Shares
13th Oct 20253:30 pmRNSDirector/PDMR Shareholding
13th Oct 20257:00 amRNSTransaction in Own Shares
10th Oct 20253:30 pmRNSDirector/PDMR Shareholding
10th Oct 20257:00 amRNSTransaction in Own Shares
9th Oct 20257:00 amRNSTransaction in Own Shares
8th Oct 20257:00 amRNSTransaction in Own Shares
7th Oct 20257:00 amRNSTransaction in Own Shares
6th Oct 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.